SUMMARY Cerebrospinal fluid (CSF) lactate and pyruvate concentrations were determined in 20 patients with diabetes mellitus but without disturbance ofconsciousness and five who recovered from hypoglycaemic coma. CSF lactate was slightly but significantly higher in diabetes mellitus (1 X78, SEM 0 04 m mol/1) than that in 15 control subjects (1 -40, SEM 0 05 m mol/l). In those who recovered from hypoglycaemic coma, CSF lactate was markedly elevated to 2-45-443 m mol/l. CSF glucose concentrations, however, were substantially the same between treated hypoglycaemic and diabetes mellitus groups. These findings indicate that CSF lactate levels increase with glycaemic levels in diabetes mellitus owing to enhanced glucose influx into glycolytic pathway of the brain, and also increases in treated hypoglycaemic coma probably due to mitochondrial dysfunction or damage. < 125 mg/dl, 87 (SEM 6) mg/dl and were treated with diet alone except for one who was treated with 20 units of insulin daily) and the remaining 12 were fairly or poorly controlled (fasting plasma glucose = 193, (SEM 33) mg/dl). The known duration of the diabetes ranged from having been discovered at the present hospital admission by an oral glucose tolerance test (five patients) to 19 years. Twelve patients demonstrated diabetic polyneuropathy with preferentially depressed vibration sense. Seven patients had a history of minor stroke including transient ischaemic attack. Lumbar puncture was performed after obtaining informed consent from each patient. In five hypoglycaemic cases who had experienced hypoglycaemic coma, CSF studies were performed 24-30 hours after immediate treatment for life threatening hypoglycaemia. The causes of hypoglycaemia were insulininduced (three patients), oral hypoglycaemic agents (one) and alcohol-induced (one). Their plasma glucose levels on admission were 22-32 mg/dl in three untreated cases, and 50-72 mg/dl in two who had been treated with glucose injection just before admission. Fifteen non-diabetic patients who had headache, dizziness or miscellaneous neurological disorders underwent lumbar puncture as a part of routine care. Since extensive examinations revealed no central nervous system disorders in these patients, the chemical indices in CSF were used as controls.
It has been reported that lactate levels in CSF increase and reflect well the severity of brain dysfunction in patients with haemorrhagic or ischaemic cerebrovascular disease,'-5 malignant hypertension6 and hepatic encephalopathy.' CSF lactate also increases in diabetic ketoacidosis with obtundation or coma. 8 However, the levels of CSF lactate have not been fully investigated in relation to the severity of hyperglycaemia or diabetes mellitus, without disturbance of consciousness. Hypoglycaemia is not uncommon in diabetic patients treated with insulin or oral hypoglycaemic agents, and may cause, though rarely, serious brain damage and death.9 To examine whether glycolytic metabolism ofthe brain is impaired or not in diabetes mellitus, we determined CSF lactate in patients with diabetes mellitus or hypoglycaemic coma.
Patients and methods
Twenty-five patients, 20 with diabetes mellitus and five with hypoglycaemia, 16 males and 9 females, aged 52 (SEM 3) years, were studied. Of the 20 patients with diabetes mellitus, eight were well controlled (fasting plasma glucose levels < 125 mg/dl, 87 (SEM 6) mg/dl and were treated with diet alone except for one who was treated with 20 units of insulin daily) and the remaining 12 were fairly or poorly controlled (fasting plasma glucose = 193, (SEM 33) mg/dl). The known duration of the diabetes ranged from having been discovered at the present hospital admission by an oral glucose tolerance test (five patients) to 19 years. Twelve patients demonstrated diabetic polyneuropathy with preferentially depressed vibration sense. Seven patients had a history of minor stroke including transient ischaemic attack. Lumbar puncture was performed after obtaining informed consent from each patient. In five hypoglycaemic cases who had experienced hypoglycaemic coma, CSF studies were performed 24-30 hours after immediate treatment for life threatening hypoglycaemia. The causes of hypoglycaemia were insulininduced (three patients), oral hypoglycaemic agents (one) and alcohol-induced (one). Their plasma glucose levels on admission were 22-32 mg/dl in three untreated cases, and 50-72 mg/dl in two who had been treated with glucose injection just before admission. Fifteen non-diabetic patients who had headache, dizziness or miscellaneous neurological disorders underwent lumbar puncture as a part of routine care. Since extensive examinations revealed no central nervous system disorders in these patients, the chemical indices in CSF were used as controls.
Immediately after sampling, 1-5 ml CSF was added to the same amount of 10% perchloric acid to remove protein, and the supernatant was stored in deep freezer until estimation. After neutralisation with 3N potassium hydroxide (pH 5 6), lactate and pyruvate in CSF were analysed by the standard enzymatic methods (Boehringer, Mannheim) as previously described.2-67 All CSF samples were clear and had normal cell counts (< 5/mm3). CSF protein and glucose concentrations were also determined. lopathy.7 In the present study, CSF lactate increased in diabetes mellitus even without any disturbance of consciousness, but it did not exceed 2-05 m mol/l. Thus, CSF lactate greater than 2-1 m mol/l seems to indicate derangement of glucose metabolism in the brain. CSF lactate pyruvate ratio in treated-hypoglycaemia was not significantly higher than controls. From our present data and those of Berger and Fawer' which showed CSF lactate pyruvate ratio and "excess"' lactate are no more significant than lactate alone, it would appear that CSF lactate elevation > 2 1 m mol/l provides a better index of hypoglycaemic or hypoxic brain damage.
As shown in a human study'2 as well as in our experimental studies,'3 hyperglycaemia per se does not disturb brain energy metabolism. Brain tissue lactate in non-ischaemic hyperglycaemic rats was 2-61, SEM 0-17 m mol/kg which was slightly higher than 2-32, SEM 0O15 in normoglycaemic rats.'3 Similarly, CSF lactate in our diabetes mellitus patients was slightly higher than in controls. In contrast, CSF lactate elevated markedly (>2 m mol/l) in those who recovered from hypoglycaemic coma. The experimental studies have clearly shown moderate elevation of brain lactate concomitant with reduced adenosine triphosphate even after recovery from profound hypoglycaemia.'4 5 Recently, Behar et a'6 also reported that brain lactate increased progressively during recovery from hypoglycaemia and suggested two possibilities for the prolonged abnormality in brain lactate metabolism: (1) an accelerated glycolytic rate, and (2) an impaired mitochondrial function. Our present results showing greatly increased CSF lactate after the treatment for hypoglycaemic coma indicate that metabolic disturbance by hypoglycaemia persists for a longer time even after recovery from coma and that increased CSF lactate relates to the severity of mitochondrial dysfunction or damage.
In conclusion, CSF lactate slightly increased in diabetic patients without disturbance of consciousness, and more markedly in hypoglycaemic patients who recovered from coma, suggesting prolonged dysfunction of brain glucose metabolism by exposure to severe hypoglycaemia.
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